Total market for bioprocessing is projected to grow by 8.7%
"The total market for bioprocessing instruments and equipment, including the sum of initial systems, aftermarket, and instrument servicing, and is expected to approach $12.4 billion by 2022," said Mike Tice, Senior Vice President, Business Intelligence at SDi. "Given the importance of bioprocessing technologies and their continued growth and ramifications into many different areas of the modern global economy, the total market needs to be segmented in various ways to make more sense of the total industry."
The goal of this report is to provide a detailed overview of the current market situation and projected potential for key bioprocessing technologies. This report identifies, in both quantitative and qualitative terms, the structure and composition of the worldwide bioprocessing market. Technical, business, and economic trends are assessed with emphasis on the impact these forces have on technology demand. The market information in this report, with the exception of the end-user survey, represents estimates of the market and provides perspectives and the relative significance of specific trends within this market.
The 2018 Bioprocessing Market Analysis and Perspectives is the most accurate, detailed and concise market research document on the bioprocessing market available anywhere. Additionally, users will receive the report in a PDF as well as an editable PowerPoint format.
A complimentary Executive Summary can be downloaded here: https://strategic-directions.com/product/2018-bioprocessing-market-analysis/
Bioprocessing instruments and techniques have become influential in everything from generating high yield pharmaceutical precursors, to biofuel conversion from biomass. This report delves into market size and growth data for bioreactors, cell culture and media, supplements, filtration, and process chromatography, covering both upstream and downstream processes. It can serve as a valuable reference for corporate planning, strategic marketing, business valuation, acquisition due diligence, and other business activities.
Strategic Directions International (SDi), a leading international management-consulting firm in the highly specialized field of analytical instruments, was acquired by BioInformatics Inc in 2014. The two firms combined to form the premier research and advisory firm serving the life science and analytical instrument industry. By leveraging our verified online professional network of tens of thousands of scientists in The Science Advisory Board®, we have supported more than 500 companies and provided insights that lead to better business decisions. Our expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers' brand loyalty, and evaluating brand strength and positioning, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning. SDi and BioInformatics Inc are members of Science and Medicine Group, supporting life science, radiology, dentistry, analytical instrument, and clinical diagnostic companies.
Senior Vice President of Business Intelligence
Strategic Directions International
A division of BioInformatics Inc.
6242 Westchester Parkway, Suite 100
Los Angeles, CA 90045-4820
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Total market for bioprocessing is projected to grow by 8.7% here
News-ID: 1238296 • Views: 1065
More Releases for Bioprocessing
Global Single-use Upstream Bioprocessing Market
According to a new market research report published by Global Market Estimates, the Global Single-use Upstream Bioprocessing Market is projected to grow from USD 8.1 Billion in 2022 to USD 24.8 Billion by 2027 at a CAGR value of 15.5% from 2022 to 2027. Danaher Corporation (Cytiva), Sartorius AG, Thermo Fisher Scientific, Inc., Merck KGaA, Corning Incorporated, Pall Corporation, General Electric Company (GE Healthcare), Eppendorf AG, Rentschler Biopharma SE, Lonza, Meissner
Global Bioprocessing Bags Market Report- Forecast 2026
According to a new market research report published by Global Market Estimates, the Global Bioprocessing Bags Market is projected to grow from USD 8.5 billion in 2021 to USD 21.1 billion by 2026 at a CAGR value of 20.7% from 2021 to 2026. The bioprocessing bag market is being driven by factors such as increasing demand for pharmaceuticals and energy consumption; rising need to minimize wastage of water, increasing flooring
Cell Therapy Bioprocessing Market 2021 | Detailed Report
ReportsnReports publishes the report titled Cell Therapy Bioprocessing that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like
Advancements In The Technology Of Bioprocessing Systems Fuelled The Global Singl …
Single-use systems are generally made up of the plastics which are being mostly sanitized and vacuum-packed using gamma radioactivity. Also, it is said that the single-use systems are bioprocessing products which are being generally used for a single time purpose and then discarded. But, problems for such as extracting and disposing of plastic bags generally provide the environmental harm. Some of the major factors that are restricting the growth of
Asia Pacific Single-use Bioprocessing Systems Market: China Outshines with Deman …
This report on single-use bioprocessing systems market studies the current as well as future prospects of the market in Asia Pacific. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various single-use bioprocessing systems instrument and products as well as new entrants planning to enter this market. Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23045 This report comprises an elaborate executive summary along with a
Single-Use Bioprocessing Systems Market 2017
The Global Single-use Bioprocessing Market was worth USD 2.42 billion in 2016 and estimated to be growing at a CAGR of 17.5%, to reach USD 5.42 Billion by 2021. The market is showcasing substantia; potential in future years and is expected to continue its growth. Single-use bioprocessing technology is majorly utilized in the manufacturing of biopharmaceuticals. The technique is used throughout the complete process of biopharmaceutical production, right from buffer and media